Research and Development

The Research and Development team at Codagenix Inc. spearheads the creation and refinement of next-generation vaccines, focusing on influenza, respiratory syncytial virus, dengue virus, and other infectious diseases. Comprising experts in virus research, synthetic vaccine development, and preclinical operations, the team leads projects from conceptualization through preclinical stages to ensure innovative and effective vaccine solutions.